Factors associated with HIV status non-disclosure among people entering care at IeDEA sites in Cameroon: a cross-sectional study.
Gespeichert in:
| Titel: | Factors associated with HIV status non-disclosure among people entering care at IeDEA sites in Cameroon: a cross-sectional study. |
|---|---|
| Autoren: | Mabou GT; Clinical Research Education Networking and Consultancy (CRENC), Yaounde, Cameroon. Mabougt27@gmail.com., Brazier E; Institute for Implementation Science in Population Health, Graduate School of Public Health and Health Policy, City University of New York (CUNY), New York, USA., Ebasone P; Clinical Research Education Networking and Consultancy (CRENC), Yaounde, Cameroon., Dzudie A; Clinical Research Education Networking and Consultancy (CRENC), Yaounde, Cameroon.; Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon.; Service of Internal Medicine, Douala General Hospital, Douala, Cameroon.; Department of Global Health and Population, Lown Scholars Program, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Hoover D; Department of Statistics and Institute for Health, Health Care Policy and Aging Research, Rutgers the State University of New Jersey, Piscataway, NJ, USA., Shi Q; Department of Public Health, New York Medical College, Valhalla, New York, USA., Barthel R; Institute for Implementation Science in Population Health, Graduate School of Public Health and Health Policy, City University of New York (CUNY), New York, USA., Ajeh R; Clinical Research Education Networking and Consultancy (CRENC), Yaounde, Cameroon., Nforniwe DN; Limbe Regional Hospital, Limbe, Cameroon., Nyenti A; Bamenda Regional Hospital, Bamenda, Cameroon., Nkodo JM; Yaounde Jamot Hospital, Yaounde, Cameroon.; Department of Morphological Sciences and Pathological Anatomy, Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon., Nash D; Institute for Implementation Science in Population Health, Graduate School of Public Health and Health Policy, City University of New York (CUNY), New York, USA.; Department of Epidemiology and Biostatistics, Graduate School of Public Health, City University of New York, New York, NY, USA., Adedimeji A; Department of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY, USA., Yotebieng M; Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA., Anastos K; Departments of Medicine and Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY, USA. |
| Quelle: | AIDS research and therapy [AIDS Res Ther] 2025 Oct 08; Vol. 22 (1), pp. 100. Date of Electronic Publication: 2025 Oct 08. |
| Publikationsart: | Journal Article |
| Sprache: | English |
| Info zur Zeitschrift: | Publisher: BioMed Central Country of Publication: England NLM ID: 101237921 Publication Model: Electronic Cited Medium: Internet ISSN: 1742-6405 (Electronic) Linking ISSN: 17426405 NLM ISO Abbreviation: AIDS Res Ther Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: [London] : BioMed Central, 2004- |
| MeSH-Schlagworte: | HIV Infections*/psychology , HIV Infections*/epidemiology , HIV Infections*/diagnosis , Self Disclosure* , Disclosure*, Humans ; Cross-Sectional Studies ; Male ; Female ; Cameroon/epidemiology ; Adult ; Middle Aged ; Social Stigma ; Young Adult ; Social Support ; Prevalence |
| Abstract: | Competing Interests: Declarations. Ethics approval and consent to participate: The IeDEA Cameroon Study was approved by the Cameroon National Ethics Committee of Research for Human Health in Yaoundé, Cameroon and by the Institutional Review Board at Albert Einstein College of Medicine. Authorized written permissions were obtained from each of the management of the study facilities. All participants provided written informed consent before their participation in the study. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests. Background: While non-disclosure of HIV status may protect people living with HIV (PLWH) against stigma, discrimination, and violence, disclosure may facilitate access to social support and improve treatment adherence. This study examined factors associated with non-disclosure among recently-diagnosed PLWH at IeDEA study sites in Cameroon. Methods: We conducted a cross-sectional study of adults ≥ 19 years newly enrolling in HIV care at three Cameroon hospitals from January 2016 to June 2023 with recent (< 1 year) diagnoses and no evidence of prior HIV care. We used logistic regression to identify factors associated with non-disclosure of HIV status at the time of enrolment. Results: Among 2880 participants, the overall prevalence of HIV status non-disclosure at enrolment was 34.4%, ranging from 48.0% among those enrolling on the day of diagnosis to 18.7% among those enrolling > 30 days after diagnosis. Men and single participants had higher odds of non-disclosure compared with women (aOR: 1.68; 95% CI 1.38, 2.04) and those who were married/living with a partner (aOR: 1.66; 95% CI 1.36, 2.02). Those with early-stage HIV disease (WHO Stage 1 or 2 or CD4 ≥ 200 cells/mm 3 ) also had higher odds of non-disclosure (aOR: 1.48; 95% CI 1.20, 1.83) compared with participants with advanced-stage disease. Conclusion: Among those diagnosed with HIV within 1 year prior to enrolment, men, single/unmarried people, and those with early-stage HIV disease were less likely to disclose their status. Further research on barriers to status disclosure among these groups is needed to guide disclosure support and counselling interventions. (© 2025. The Author(s).) |
| References: | AIDS. 2007 Jan;21 Suppl 1:S89-94. (PMID: 17159594) PLOS Glob Public Health. 2023 Apr 7;3(4):e0000556. (PMID: 37027350) AIDS Res Treat. 2020 Nov 06;2020:7165423. (PMID: 33204528) Trop Doct. 2006 Apr;36(2):87-9. (PMID: 16611440) HIV AIDS (Auckl). 2023 Jun 08;15:293-311. (PMID: 37312814) Sex Transm Dis. 2006 Feb;33(2):102-5. (PMID: 16432481) J Acquir Immune Defic Syndr. 2011 Jul 1;57 Suppl 1:S22-6. (PMID: 21857281) Front Public Health. 2022 Nov 22;10:919410. (PMID: 36483255) Int J Drug Policy. 2021 Dec;98:103431. (PMID: 34534821) Pan Afr Med J. 2021 Nov 02;40:129. (PMID: 34909097) AIDS Educ Prev. 2011 Feb;23(1):78-90. (PMID: 21341962) AIDS Care. 2008 Nov;20(10):1266-75. (PMID: 18608080) Global Health. 2018 Jun 5;14(1):56. (PMID: 29866206) AIDS Patient Care STDS. 2010 Oct;24(10):675-81. (PMID: 20863244) BMC Public Health. 2008 Feb 29;8:81. (PMID: 18312653) AIDS Behav. 2017 Jan;21(1):70-81. (PMID: 26781869) AIDS Behav. 2014 Jun;18(6):1037-45. (PMID: 24385230) Ann Glob Health. 2021 Jun 18;87(1):49. (PMID: 34164262) BMC Public Health. 2014 Oct 11;14:1061. (PMID: 25304035) AIDS Care. 2020 Dec;32(12):1565-1572. (PMID: 32122168) AIDS. 1995 Jun;9(6):639-44. (PMID: 7662205) AIDS Care. 2017 Jul;29(7):838-845. (PMID: 28024412) AIDS Behav. 2008 Mar;12(2):232-43. (PMID: 17828450) AIDS Behav. 2013 Jan;17(1):360-8. (PMID: 23054043) AIDS Care. 2012;24(9):1092-6. (PMID: 22799616) BMC Res Notes. 2015 Mar 29;8:109. (PMID: 25889779) AIDS Patient Care STDS. 2012 Mar;26(3):181-90. (PMID: 22256856) BMC Infect Dis. 2020 May 29;20(1):382. (PMID: 32471358) J Int AIDS Soc. 2021 Jun;24(6):e25672. (PMID: 34152663) PLoS One. 2019 Feb 15;14(2):e0211967. (PMID: 30768642) Am J Public Health. 2011 Jun;101(6):1011-23. (PMID: 21493947) Reprod Health. 2017 Aug 30;14(1):107. (PMID: 28854944) Am J Public Health. 2007 Oct;97(10):1775-81. (PMID: 17761582) J Acquir Immune Defic Syndr. 2014 Dec 1;67 Suppl 4:S235-42. (PMID: 25436823) JAMA. 2020 Jun 9;323(22):2290-2300. (PMID: 32515813) AIDS Behav. 2022 Mar;26(3):651-661. (PMID: 34403021) AIDS. 2001 Sep 28;15(14):1865-74. (PMID: 11579250) AIDS Care. 2011 Sep;23(9):1059-66. (PMID: 21480006) J Pregnancy. 2012;2012:851810. (PMID: 22523689) AIDS Behav. 2007 Sep;11(5):698-705. (PMID: 17082982) Eur J Med Res. 2022 Apr 8;27(1):56. (PMID: 35395935) Medicine (Baltimore). 2019 Aug;98(31):e16681. (PMID: 31374050) J Pers Soc Psychol. 2009 Oct;97(4):634-51. (PMID: 19785483) AIDS Behav. 2018 Dec;22(12):3933-3944. (PMID: 30155586) AIDS Care. 2011 Feb;23(2):195-205. (PMID: 21259132) AIDS Educ Prev. 2016 Aug;28(4):287-98. (PMID: 27427924) AIDS Care. 2015;27 Suppl 1:59-64. (PMID: 26616126) AIDS Behav. 2015 Oct;19(10):1763-72. (PMID: 25645328) BMC Public Health. 2013 May 03;13:433. (PMID: 23641927) J Clin Diagn Res. 2015 Aug;9(8):OC14-6. (PMID: 26435983) Soc Sci Med. 2009 Sep;69(6):885-91. (PMID: 19560244) AIDS Behav. 2017 Jan;21(1):1-11. (PMID: 27406227) |
| Grant Information: | U01AI096299 United States NH NIH HHS; U01AI096299 United States NH NIH HHS; U01AI096299 United States NH NIH HHS; U01AI096299 United States NH NIH HHS; U01AI096299 United States NH NIH HHS; U01AI096299 United States NH NIH HHS; U01AI096299 United States NH NIH HHS; U01AI096299 United States NH NIH HHS; U01AI096299 United States NH NIH HHS; U01AI096299 United States NH NIH HHS; U01AI096299 United States NH NIH HHS; U01AI096299 United States NH NIH HHS; U01AI096299 United States NH NIH HHS; U01AI096299 United States NH NIH HHS; U01AI096299 United States NH NIH HHS |
| Contributed Indexing: | Keywords: Cameroon; HIV status disclosure; IeDEA; Patients living with HIV |
| Entry Date(s): | Date Created: 20251008 Date Completed: 20251009 Latest Revision: 20251012 |
| Update Code: | 20251012 |
| PubMed Central ID: | PMC12505618 |
| DOI: | 10.1186/s12981-025-00765-1 |
| PMID: | 41063261 |
| Datenbank: | MEDLINE |
Full Text 
Full Text Finder 
Nájsť tento článok vo Web of Science | Abstract: | Competing Interests: Declarations. Ethics approval and consent to participate: The IeDEA Cameroon Study was approved by the Cameroon National Ethics Committee of Research for Human Health in Yaoundé, Cameroon and by the Institutional Review Board at Albert Einstein College of Medicine. Authorized written permissions were obtained from each of the management of the study facilities. All participants provided written informed consent before their participation in the study. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.<br />Background: While non-disclosure of HIV status may protect people living with HIV (PLWH) against stigma, discrimination, and violence, disclosure may facilitate access to social support and improve treatment adherence. This study examined factors associated with non-disclosure among recently-diagnosed PLWH at IeDEA study sites in Cameroon.<br />Methods: We conducted a cross-sectional study of adults ≥ 19 years newly enrolling in HIV care at three Cameroon hospitals from January 2016 to June 2023 with recent (< 1 year) diagnoses and no evidence of prior HIV care. We used logistic regression to identify factors associated with non-disclosure of HIV status at the time of enrolment.<br />Results: Among 2880 participants, the overall prevalence of HIV status non-disclosure at enrolment was 34.4%, ranging from 48.0% among those enrolling on the day of diagnosis to 18.7% among those enrolling > 30 days after diagnosis. Men and single participants had higher odds of non-disclosure compared with women (aOR: 1.68; 95% CI 1.38, 2.04) and those who were married/living with a partner (aOR: 1.66; 95% CI 1.36, 2.02). Those with early-stage HIV disease (WHO Stage 1 or 2 or CD4 ≥ 200 cells/mm <sup>3</sup> ) also had higher odds of non-disclosure (aOR: 1.48; 95% CI 1.20, 1.83) compared with participants with advanced-stage disease.<br />Conclusion: Among those diagnosed with HIV within 1 year prior to enrolment, men, single/unmarried people, and those with early-stage HIV disease were less likely to disclose their status. Further research on barriers to status disclosure among these groups is needed to guide disclosure support and counselling interventions.<br /> (© 2025. The Author(s).) |
|---|---|
| ISSN: | 1742-6405 |
| DOI: | 10.1186/s12981-025-00765-1 |